Blog

RNA-targeting CRISPR could yield treatments for Huntington’s, ALS – FierceBiotech


FierceBiotech

RNA-targeting CRISPR could yield treatments for Huntington's, ALS
FierceBiotech
CRISPR uses the Cas9 enzyme and a "guide" RNA to snip out mutations in DNA, but until recently, it has not been used to target RNA. After using the method to track RNA in live cells last year, the UC San Diego team is now correcting mistakes in RNA

2017-08-11 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.